Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2022	$ 4,084,649	$ 28	$ 119,731,764	$ (115,647,143)
Beginning Balance, Shares at Dec. 31, 2022		278,558
Stock-based compensation expense	284,572		284,572
Net loss	(2,243,070)			(2,243,070)
Ending Balance at Mar. 31, 2023	2,126,151	$ 28	120,016,336	(117,890,213)
Ending Balance, Shares at Mar. 31, 2023		278,558
Beginning Balance at Dec. 31, 2022	4,084,649	$ 28	119,731,764	(115,647,143)
Beginning Balance, Shares at Dec. 31, 2022		278,558
Net loss	(4,110,987)
Ending Balance at Jun. 30, 2023	538,374	$ 28	120,296,476	(119,758,130)
Ending Balance, Shares at Jun. 30, 2023		278,558
Beginning Balance at Mar. 31, 2023	2,126,151	$ 28	120,016,336	(117,890,213)
Beginning Balance, Shares at Mar. 31, 2023		278,558
Stock-based compensation expense	280,140		280,140
Net loss	(1,867,917)			(1,867,917)
Ending Balance at Jun. 30, 2023	538,374	$ 28	120,296,476	(119,758,130)
Ending Balance, Shares at Jun. 30, 2023		278,558
Beginning Balance at Dec. 31, 2023	$ (2,579,537)	$ 28	120,859,873	(123,439,438)
Beginning Balance, Shares at Dec. 31, 2023	278,558	278,558
Stock-based compensation expense	$ 254,029		254,029
Issuance of common stock, Pre-Funded Warrants, Series A Warrants, Series B Warrants, and Series C Warrants net of issuance costs	6,172,623	$ 43	6,172,580
Issuance of common stock, Pre-Funded Warrants, Series A Warrants, Series B Warrants, and Series C Warrants net of issuance costs, shares		427,886
Amendment and issuance of common stock and Pre-Funded Warrants from exercise of Series B Warrants, net of issuance costs	1,229,874	$ 1	1,229,873
Amendment and issuance of common stock and Pre-Funded Warrants from exercise of Series B Warrants, net of issuance costs, shares		9,967
Net loss	(1,579,820)			(1,579,820)
Ending Balance at Mar. 31, 2024	3,497,169	$ 72	128,516,355	(125,019,258)
Ending Balance, Shares at Mar. 31, 2024		716,411
Beginning Balance at Dec. 31, 2023	$ (2,579,537)	$ 28	120,859,873	(123,439,438)
Beginning Balance, Shares at Dec. 31, 2023	278,558	278,558
Net loss	$ (2,847,038)
Ending Balance at Jun. 30, 2024	$ 2,664,958	$ 73	128,951,361	(126,286,476)
Ending Balance, Shares at Jun. 30, 2024	734,836	734,836
Beginning Balance at Mar. 31, 2024	$ 3,497,169	$ 72	128,516,355	(125,019,258)
Beginning Balance, Shares at Mar. 31, 2024		716,411
Stock-based compensation expense	126,578		126,578
Issuance of common stock from cashless exercise of pre-funded warrants		$ 1	(1)
Issuance of common stock from cashless exercise of pre-funded warrants, Shares		18,425
Amendment and issuance of common stock and Pre-Funded Warrants from exercise of Series B Warrants, net of issuance costs	308,429		308,429
Net loss	(1,267,218)			(1,267,218)
Ending Balance at Jun. 30, 2024	$ 2,664,958	$ 73	$ 128,951,361	$ (126,286,476)
Ending Balance, Shares at Jun. 30, 2024	734,836	734,836